98273591 - EXABLATE PRIME

Information

  • Trademark
  • 98273591
  • Serial Number
    98273591
  • Filing Date
    November 16, 2023
    6 months ago
  • Transaction Date
    May 01, 2024
    a month ago
  • Status Date
    November 20, 2023
    6 months ago
  • Location Date
    November 20, 2023
    6 months ago
  • Status Code
    630
  • Current Location
    NEW APPLICATION PROCESSING
  • Attorney Docket Number
    2836-0091
    Attorney Name
    Julia Anne Matheson
  • Owners
Mark Drawing Code
4
Mark Identification
EXABLATE PRIME
Case File Statements
  • GS0091: Downloadable software for use in medical screening, diagnostics, and medical therapy, namely, for conducting guided ultrasound; downloadable computer software, namely, for the management and operation of medical ultrasound systems sold as a component of an ultrasound apparatus for therapeutic and diagnostic medical purposes; downloadable software for use in the treatment of neurological, oncological, gynecological, and urological disease by means of guided ultrasound; downloadable computer software for use in the treatment of central nervous system disorders, neurodegenerative disease, neuro-oncological disease, neuropsychiatric and behavioral disorders, movement disorders, prostate cancer, uterine fibroids and bone metastases by means of guided ultrasound sold as a component of an ultrasound apparatus for therapeutic and diagnostic medical purposes
  • GS0101: Medical ultrasound apparatus; ultrasound diagnostic apparatus and user manuals sold as a unit therewith; ultrasound apparatus for therapeutic and diagnostic medical procedures in the fields of neurology, oncology, gynecology and urology; ultrasound apparatus for therapeutic and diagnostic medical procedures with respect to central nervous system disorders, neurodegenerative disease, neuro-oncological disease, neuropsychiatric and behavioral disorders, movement disorders, prostate cancer, uterine fibroids and bone metastases; ultrasound apparatus for therapeutic and diagnostic medical procedures, namely, for use in the ablation of tissue, sonication of tissue, and disruption of the blood brain barrier, by itself or in combination with other therapies
Case File Event Statements
  • 12/22/2023 - 5 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/20/2023 - 6 months ago
    1 - NEW APPLICATION ENTERED Type: NWAP